Dr Ernst Jochen Meyer, MD in Belmont, MA - Ophthalmology

Dr Ernst Jochen Meyer, MD is a Ophthalmology physician based in Belmont, Massachusetts. Dr Ernst Jochen Meyer is licensed to practice in Massachusetts (license number 24584) and his current practice location is 174 School St, Belmont, Massachusetts. He can be reached at his office (for appointments etc.) via phone at (617) 484-8109.

NPI number for Dr Ernst Jochen Meyer is 1780743880 and his current mailing address is 174 School St, Belmont, Massachusetts. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1780743880.

Contact Information

	Dr Ernst Jochen Meyer, MD
	174 School St, Belmont, MA 02478-3547
	(617) 484-8109
	Not Available

Physician's Profile

Full Name	Dr Ernst Jochen Meyer
Gender	Male
Speciality	Ophthalmology
Location	174 School St, Belmont, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1780743880
Provider Enumeration Date: 12/06/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Ernst Jochen Meyer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1780743880	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	24584 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ernst Jochen Meyer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Ernst Jochen Meyer, MD 174 School St, Belmont, MA 02478-3547 Ph: (617) 484-8109	Dr Ernst Jochen Meyer, MD 174 School St, Belmont, MA 02478-3547 Ph: (617) 484-8109

News Archive

Oramed presents ORMD-0801 Phase IIb results for Type II diabetes at Annual Meeting in Bethesda

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, presented the results of its recently completed Phase IIb trial. The multicenter, placebo-controlled, randomized, double-blind study conducted in 29 patients with Type II diabetes assessed the safety of ORMD-0801 in patients with Type II diabetes.

For Covid ‘long haulers,' battling for disability benefits adds aggravation to exhaustion

Rickie Andersen took a brief break from work in March after she fell ill. Her cough, fever and chills were typical covid-19 symptoms, but coronavirus tests were so scarce she could not obtain one to confirm the diagnosis.

Horn of Africa nations risk 'massive famine,' Shah says

The nations in the drought-stricken Horn of Africa "are at risk of 'massive famine,' Rajiv Shah, the administrator of the U.S. Agency for International Development (USAID), told the Huffington Post Wednesday."

BMI not associated with esophageal cancer patient survival

Researchers at Moffitt Cancer Center in Tampa, Fla., have found - contrary to previous studies linking inferior outcomes in patients with gastrointestinal malignancies to higher body mass index (BMI) - that in their study of BMI and negative outcomes, there was no such link. They concluded that BMI was not associated with either surgical complications or esophageal cancer patient survival.

NHLBI's The Heart Truth to showcase Red Dress Collection 2012 on Feb. 8

As part of American Heart Month, on Wednesday, Feb. 8, 2012, the National Heart, Lung, and Blood Institute's (NHLBI's) The Heart Truth campaign, with the support of the Foundation for the National Institutes of Health (FNIH), will showcase its signature event, the Red Dress Collection 2012 at Mercedes-Benz Fashion Week in New York City.

Dr Ernst Jochen Meyer, MD - Ophthalmology in Belmont, MA